|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: STEARNS & LEHMAN INC, 10QSB, 2000-12-12 |
Next: TRANSKARYOTIC THERAPIES INC, 8-K, 2000-12-12 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> APR-30-2001
<PERIOD-START> MAY-01-2000
<PERIOD-END> OCT-31-2000
<CASH> 864,663
<SECURITIES> 0
<RECEIVABLES> 2,847,794
<ALLOWANCES> (61,068)
<INVENTORY> 2,286,899
<CURRENT-ASSETS> 6,076,687
<PP&E> 5,300,993
<DEPRECIATION> (1,560,736)
<TOTAL-ASSETS> 11,308,823
<CURRENT-LIABILITIES> 2,056,198
<BONDS> 1,221,994
0
0
<COMMON> 3,629
<OTHER-SE> 7,638,270
<TOTAL-LIABILITY-AND-EQUITY> 11,308,823
<SALES> 9,634,236
<TOTAL-REVENUES> 9,670,601
<CGS> 6,485,981
<TOTAL-COSTS> 8,353,135
<OTHER-EXPENSES> 10,152
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 74,143
<INCOME-PRETAX> 1,233,171
<INCOME-TAX> 479,443
<INCOME-CONTINUING> 753,727
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 753,727
<EPS-BASIC> .23
<EPS-DILUTED> .23
</TABLE>
|
|